SCHEMBL3238745

SCHEMBL3238745

CN1CCN(c2ccccc2)c2ccc(F)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
SLC6A2 P23975 6/20 0.45
SLC6A4 P31645 5/20 0.45
SLC6A3 Q01959 2/20 0.45
SCN9A Q15858 1/20 0.42
MAOA P21397 2/20 0.39
MAOB P27338 2/20 0.39
MAPK1 P28482 2/20 0.38
HTR3E A5X5Y0 1/20 0.37
HTR3B O95264 1/20 0.37
HTR3A P46098 1/20 0.37
HTR3D Q70Z44 1/20 0.37
HTR3C Q8WXA8 1/20 0.37
ADRA2C P18825 1/20 0.37
P2RX7 Q99572 1/20 0.37
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
GFER P55789 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3235072 0.91 ALDH1A1 (0.50) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3227991 0.90 ALDH1A1 (0.47) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3479743 0.87 ALDH1A1 (0.49) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3218294 0.86 ALDH1A1 (0.46) ALDH1A1L3MBTL1SCN9AP2RX7MAPT
SCHEMBL3233131 0.85 HTR3A (0.51) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3225923 0.85 DRD2 (0.48) ALDH1A1L3MBTL1SCN9AMAPT
SCHEMBL3224500 0.84 SLC6A2 (0.48) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3235658 0.84 SLC6A2 (0.43) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3479611 0.83 ALDH1A1 (0.46) ALDH1A1L3MBTL1SLC6A2SLC6A4SLC6A3
SCHEMBL3479777 0.82 ADRA2C (0.51) ALDH1A1SLC6A4SCN9AMAPK1HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed
EP-2146722-A1 ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR Technology, Inc. (US) 2010-01-27 EP disclosed
WO-2008141081-A1 ARYL- AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN AMR TECHNOLOGY, INC. (US) 2008-11-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D ALDH1A1 372/4885L3MBTL1 2286/4885SLC6A2 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.